Kobena Veterinary Company Limited most respected Veterinary Company manufacturing COVID-19 Vaccines and all over hundreds of various lifesaving Bio-Veterinary products, Animal Supplements.

The plant has an annual capacity of more than 3 billion oral solid dosage formulations. With an enviable location on the easily accessible, the plant is a preferred destination for contract manufacturing and site variation for general category tablets, capsules and sachets.

The facility has been built in line with latest regulatory requirements with a view to comply with USA and European Manufacturing Law.

It is equipped with sophisticated USA & Europe Veterinary Law automated machines at each step of manufacturing.

Our strength is the team with wide experience in internationally reputed environment including contract manufacturing related aspects.

Kobena Veterinary Company Limited is poised to be a leading destination in contract manufacturing space in USA and all over Europe.

Brand new unit matching all relevant norms of regulatory authorities.

• Dedicated contract manufacturing operations for regulated markets.
• No conflict of interests as Kobena Veterinary Company Limited present in the European & American market with own products or brands.
• Professional corporate set-up ensures efficient management of operations
• Relevant experience: Kobena Veterinary Company Limited has experience of regulatory processes ISO certification and USA Veterinary Law aspects.
• Financially sound to support the investments required.
• Layout to match the regulatory requirements as per Ghana, WHO and other international regulatory agencies.
• Logical man and material movement to ensure unidirectional flow avoiding cris cross.
• Flexibility in operations, design of various parameters ensures quick changeover between products.
• Separate two lines, one for tablets and one for capsules, minimizing the risk of contamination or cross-contamination.